Visby Medical is a developer of diagnostic testing devices based on polymerase chain reaction (PCR), specifically designed for the detection of infectious diseases. The company excels in creating single-use handheld over-the-counter testing kits that yield instrument-free results. Visby Medical provides services for various health tests, including sexual health, respiratory health, and other infectious diseases such as covid-19, chlamydia, gonorrhea, and trichomonas. This makes infectious disease testing as easy and accessible as possible for patients.

Investors Include:

Nissim Capital, Highbury Group, Hutchison Port Group, Amplify Partners, Rheinest, Lightrock, Ling Wong, Ping An Voyager Partners, J-Ventures, Healthcare of Ontario Pension Plan, Blue Water Life Science Advisors, Cedars-Sinai, John Doerr, E Squared Capital Management, 1809 Capital, Omron Ventures, ND Capital, Dynamic Loop Capital, Artiman Ventures, Terrapin Partners, Pitango Venture Capital, Justin Mateen, Biomedical Advanced Research and Development Authority, Seraph Group, National Institutes of Health.

Looking to sell Visby Medical Stock or Options?

We have an even better solution: The Collective Exchange Fund

Get in touch and see if we can help you